广发纳斯达克生物科技人民币(001092)

动态评分: 5.28分

投资组合

报告日期 名称 比例
2020-12-31 OptiNose Inc 0.02%
2020-12-31 RVL Pharmaceuticals plc 0.02%
2020-12-31 Solid Biosciences Inc 0.02%
2020-12-31 GlycoMimetics Inc 0.02%
2020-12-31 Xeris制药 0.02%
2020-12-31 ProQR Therapeutics NV 0.02%
2020-12-31 Orchard Therapeutics plc ADR 0.02%
2020-12-31 Chiasma Inc 0.02%
2020-12-31 PDL BioPharma Inc 0.02%
2020-12-31 Voyager Therapeutics Inc 0.02%
2020-12-31 Assembly Biosciences Inc 0.02%
2020-12-31 Evolus Inc 0.01%
2020-12-31 ADMA Biologics Inc 0.01%
2020-12-31 Gritstone bio Inc 0.01%
2020-12-31 Unity Biotechnology Inc 0.01%
2020-12-31 Corbus Pharmaceuticals Holdings Inc 0.01%
2020-12-31 LENSAR Inc 0%
2020-12-31 Insys Therapeutics Inc 0%
2020-12-31 Synergy Pharmaceuticals Inc 0%
2020-09-30 吉利德科学 7.1%

投资模拟

公告&资料